CryoPort, Inc. (NASDAQ:CYRX) is set to issue its quarterly earnings data after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.08) per share for the quarter.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Tuesday, August 8th. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01. The company had revenue of $2.92 million for the quarter, compared to analysts’ expectations of $2.84 million. CryoPort had a negative net margin of 102.89% and a negative return on equity of 67.75%. On average, analysts expect CryoPort to post $-0.72 EPS for the current fiscal year and $-0.72 EPS for the next fiscal year.

Shares of CryoPort, Inc. (NASDAQ CYRX) traded up 0.27% during trading on Friday, hitting $7.39. 120,669 shares of the stock were exchanged. The firm’s 50 day moving average price is $8.89 and its 200-day moving average price is $5.81. CryoPort, Inc. has a 52 week low of $1.88 and a 52 week high of $10.40. The stock’s market cap is $182.34 million.

CYRX has been the subject of several recent analyst reports. Janney Montgomery Scott increased their price objective on shares of CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a research report on Tuesday, October 3rd. Cowen and Company reiterated an “outperform” rating and set a $11.00 price objective (up from $7.50) on shares of CryoPort in a research report on Tuesday, September 12th. Finally, Needham & Company LLC increased their price objective on shares of CryoPort from $8.50 to $10.00 and gave the stock a “buy” rating in a research report on Wednesday, August 30th.

A hedge fund recently raised its stake in CryoPort stock. Northern Trust Corp lifted its position in shares of CryoPort, Inc. (NASDAQ:CYRX) by 105.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,179 shares of the company’s stock after buying an additional 11,358 shares during the quarter. Northern Trust Corp owned about 0.09% of CryoPort worth $109,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 12.12% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “CryoPort, Inc. (CYRX) to Release Quarterly Earnings on Thursday” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with's FREE daily email newsletter.